Exact Mass: 311.123

Exact Mass Matches: 311.123

Found 32 metabolites which its exact mass value is equals to given mass value 311.123, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

N2N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.123)


CONFIDENCE standard compound; INTERNAL_ID 311 N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   

N2,N2-Dimethylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(dimethylamino)-6,9-dihydro-3H-purin-6-one

C12H17N5O5 (311.123)


N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. The mean levels of urinary N2,N2-Dimethylguanosine in the patients with colorectal cancer are significantly higher than those in patients with intestinal villous adenoma or the healthy adults (PMID 15991285). N2,N2-Dimethylguanosine has been identified in the human placenta (PMID: 32033212). N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   

1,7-Dimethylguanosine

2-amino-9-[(2R,3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-oxidooxolan-2-yl]-1,7-dimethyl-6-oxo-6,7-dihydro-1H-9λ⁵-purin-9-ylium

C12H17N5O5 (311.123)


1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216) [HMDB] 1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216).

   
   

N2,N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE10

N2,N2-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE20

N2,N2-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE30

N2,N2-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE40

N2,N2-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE0; CorrDec

N,N-Dimethylguanosine; AIF; CE0; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE10; CorrDec

N,N-Dimethylguanosine; AIF; CE10; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE30; CorrDec

N,N-Dimethylguanosine; AIF; CE30; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE10

N,N-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE20

N,N-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE30

N,N-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE40

N,N-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.123)


   

1,7-Dimethylguanosine

1,7-Dimethylguanosine

C12H17N5O5 (311.123)


   

Ganciclovir Mono-O-propionate

Ganciclovir Mono-O-propionate

C12H17N5O5 (311.123)


   

2-C-methyl-6-O-methyl-guanosine

2-C-methyl-6-O-methyl-guanosine

C12H17N5O5 (311.123)


   

N6-(2-Hydroxyethyl)adenosine

N6-(2-Hydroxyethyl)adenosine

C12H17N5O5 (311.123)


N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

C12H17N5O5 (311.123)


   

N(6)-Dnp-Lys-NH2

N(6)-Dnp-Lys-NH2

C12H17N5O5 (311.123)


   

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

C12H17N5O5 (311.123)


   

N(2),N(2)-Dimethylguanosine

N(2),N(2)-Dimethylguanosine

C12H17N5O5 (311.123)


A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups.

   

Dimethylguanosine

Dimethylguanosine

C12H17N5O5 (311.123)


   

2′-O-Methyl-8-methyl guanosine

2′-O-Methyl-8-methyl guanosine

C12H17N5O5 (311.123)


2′-O-Methyl-8-methyl guanosine (m8Gm) is a Z-form RNA stabilizer. 2′-O-Methyl-8-methyl guanosine can markedly stabilize the Z-RNA at low salt conditions[1]. m8Gm-contained oligonucleotides stabilize the Z-DNA under low salt conditions[2].

   

(2r,3r,4s,5r)-2-{6-[(2-hydroxyethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-{6-[(2-hydroxyethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C12H17N5O5 (311.123)


   

adenosine,6n-2-hydroxyethyl

adenosine,6n-2-hydroxyethyl

C12H17N5O5 (311.123)


   

2-[2-(dimethylamino)-6-hydroxypurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[2-(dimethylamino)-6-hydroxypurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C12H17N5O5 (311.123)